Adult patients (> 18 years of age) undergoing palliative care (defined by the WHO as active, comprehensive care given to patients whose condition does not respond to curative treatment) of their disease, able to communicate, and with a functional central venous line with reflux, presenting spontaneous pain with a numerical scale greater than 3 or paracetamol as part of their usual treatment.

• Pilot study of the pharmacokinetic profile of subcutaneous versus intravenous paracetamol in palliative patients Pending
  2024-518795-31-00 10

Showing 1–1 of 1 trials